Inflammatory markers associated with COPD were linked to increased symptom burden, a greater number of exacerbations, and decreased 6-minute walk distance in smokers with preserved spirometry.
Wixela Inhub has been made available by Mylan for the treatment of asthma and COPD.
COPD is prone to false positive diagnoses.
A comprehensive research bronchoscopy procedure, including oral sampling, bronchoalveolar lavage, endobronchial biopsy, and brushing can be safely performed in COPD.
Compared with dual therapy, triple therapy was associated with reduced risk for severe exacerbation of COPD and better FEV1.
Mylan plans to make Wixela Inhub available in 3 strengths: 100mcg/50mcg, 250mcg/50mcg, and 500mcg/50mcg.
Nearly 6% of older adults account for more than 20% of emergency department visits.
In patients with moderate to severe COPD, indacaterol/glycopyrronium treatment is associated with improvements in regional ventilation and pulmonary microvascular blood flow.
The Depression, Anxiety, and Stress Scale (DASS-21) demonstrated validity in individuals with COPD underwent an 8-week pulmonary rehabilitation program.
The review showed supplementation was only effective for baseline vitamin D levels <25 nmol/L.
Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.
Influenza-positive patients have higher rates of crude mortality and critical illness vs influenza-negative patients.
Patients with comorbid stable COPD and chronic hypercapnic respiratory failure have improved symptoms and survival rates with high-intensity noninvasive ventilation.
The GOLD scientific committee published a report on current controversies in COPD, including the role of cigarette smoking vs biomass exposure, the role of thoracic imaging, and different treatment strategies.
The COPD assessment test proved to be valid and reproducible in assessing the impact effect and severity of bronchiectasis symptoms in patients with COPD.
The odds of developing COPD were considerably higher in both men and women with class III obesity compared with normal weight individuals.
Cognitive behavioral therapy interventions were statistically and clinically superior to self-help leaflets in the treatment of anxiety in patients with COPD.
Patients with COPD who were considered frail were more likely to have lower quality of life, increased rate and length of hospitalization, and a higher rate of mortality.
Compared with usual care, a comprehensive 3-month program combining transition and long-term self-management support for patients with COPD led to significantly fewer COPD-related hospitalizations and greater quality of life.
A strong dose-response relationship was seen in never-smokers aged 50 and older.